Study Links High-Dose Vitamin D to Improved Cognitive Function in Older Adults
According to the World Health Organization, approximately 57 million people worldwide were living with dementia in 2021, a term encompassing various diseases that affect cognitive abilities, including Alzheimer’s disease. Early signs of dementia often manifest as mild cognitive impairment (MCI), which can include memory loss, difficulty in problem-solving, and challenges in speech and word recall, along with sleep disturbances.
Research has indicated that diet plays a crucial role in slowing the progression of dementia. Nutrient-rich foods, particularly those high in omega-3 fatty acids, B vitamins, antioxidants, and vitamin D, are thought to be beneficial. A new study published in the journal Sleep Medicine has found a correlation between higher vitamin D intake and improved cognitive function in older adults experiencing both MCI and sleep issues.
The study involved 54 participants, averaging 67 years old, who were diagnosed with or suspected to have MCI and reported sleep problems. Cognitive assessments were conducted using the Montreal Cognitive Assessment (MoCA), while sleep quality was evaluated through the Pittsburgh Sleep Quality Index (PSQI) and the Epworth Sleepiness Scale (ESS). Participants self-reported their daily vitamin D intake.
Victoria Pak, PhD, MS, MTR, an associate professor at Emory University and the study's senior author, highlighted the significance of vitamin D due to its common presence in daily life and its potential role in cognitive health. The researchers aimed to investigate the association between vitamin D intake and cognitive function in individuals with both sleep disturbances and MCI.
The findings revealed that participants who consumed 5,000 international units (IU) or more of vitamin D daily scored over 13% higher on the MoCA compared to those who did not take supplements. Pak noted that the difference was approximately four points on the MoCA, emphasizing the need for careful interpretation due to the observational nature of the study.
Next steps include clinical trials to further examine whether vitamin D supplementation can positively influence cognitive function. If confirmed, this could lead to new strategies for supporting cognitive health.
Experts not involved in the study expressed optimism about the findings. Manisha Santosh Parulekar, MD, highlighted the potential of dietary changes as a non-invasive intervention for at-risk populations. Dung Trinh, MD, noted the relevance of the findings, particularly given the commonality of sleep disturbances in patients with MCI.
Trinh cautioned that while the study showed an association between high-dose vitamin D and better cognitive scores, it was a small cross-sectional study, and larger, more rigorous research is warranted. He suggested that vitamin D might help improve cognitive function through its role in regulating inflammation and immune responses, which are linked to sleep quality and cognitive decline.
Monique Richard, MS, RDN, emphasized that vitamin D influences various pathways related to brain health and that addressing deficiencies could be a vital part of cognitive health strategies. She advised individuals to consider their overall health picture rather than immediately resorting to high-dose supplements.
For those with limited sun exposure or dietary intake, Richard recommended consulting healthcare providers to determine if supplementation is appropriate, tailored to individual health needs. She cautioned against interpreting the 5,000 IU dosage as a universal recommendation, noting that the NIH suggests a tolerable upper intake level of 4,000 IU per day for most adults.
The overarching goal is to identify whether vitamin D is a crucial element in an individual's health and how best to address this need to support both cognitive and overall health.




